ABI

Adamant Biomedical Investments Portfolio holdings

AUM $418M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$401M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
96
New
Increased
Reduced
Closed

Top Buys

1
+$19.2M
2
+$18.7M
3
+$18.1M
4
CYTO
Altamira Therapeutics Ltd
CYTO
+$13.4M
5
AMGN icon
Amgen
AMGN
+$13.1M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 86.61%
2 Financials 1.21%
3 Industrials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
76
DELISTED
Medicines Co
MDCO
$1.12M 0.28%
+50,000
LDRH
77
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$1.03M 0.26%
+33,000
MYGN icon
78
Myriad Genetics
MYGN
$452M
$926K 0.23%
+24,000
NPSP
79
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$884K 0.22%
+34,000
ACAD icon
80
Acadia Pharmaceuticals
ACAD
$3.77B
$867K 0.22%
+35,000
ACHN
81
DELISTED
Achillion Pharmaceuticals
ACHN
$798K 0.2%
+80,000
AFFX
82
DELISTED
Affymetrix Inc
AFFX
$798K 0.2%
+100,000
COR icon
83
Cencora
COR
$60.6B
$773K 0.19%
+10,000
NBIX icon
84
Neurocrine Biosciences
NBIX
$13.1B
$705K 0.18%
+45,000
IMMU
85
DELISTED
Immunomedics Inc
IMMU
$558K 0.14%
+150,000
HALO icon
86
Halozyme
HALO
$7.89B
$546K 0.14%
+60,000
WCG
87
DELISTED
Wellcare Health Plans, Inc.
WCG
$483K 0.12%
+8,000
IPXL
88
DELISTED
Impax Laboratories, Inc.
IPXL
$474K 0.12%
+20,000
EXEL icon
89
Exelixis
EXEL
$11.7B
$459K 0.11%
+300,000
CLDX icon
90
Celldex Therapeutics
CLDX
$2.63B
$389K 0.1%
+2,000
VIVS
91
VivoSim Labs
VIVS
$4.28M
$319K 0.08%
+208
TBPH icon
92
Theravance Biopharma
TBPH
$840M
$263K 0.07%
+11,428
INFI
93
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$228K 0.06%
+17,000
GERN icon
94
Geron
GERN
$961M
$90K 0.02%
+45,000
DNDN
95
DELISTED
DENDREON CORPORATION
DNDN
$72K 0.02%
+50,000
1 2 3
4